Resilience BioServices provides investment capital and strategic advisory services to emerging healthcare and pharmaceutical services companies. The firm has played a key role in launching and scaling new businesses across the pharma services sector, with recent successful transactions involving HUB services, third-party logistics (3PL), and home infusion organizations.